Lumexa Imaging Holdings Inc. (Ticker: LMRI US) is a United States-based company specializing in the provision of diagnostic imaging services. The company reportedly operates one of the largest national networks of its kind; as of September 30, 2025, Lumexa managed the second-largest outpatient imaging center footprint in the United States, with facilities located across 13 states. The company plans to list on the NASDAQ on December 11, 2025.

According to filing documents, Lumexa Imaging plans to offer 25 million shares within a price range of $17.00 to $20.00 per share. The total offer size is approximately $463 million USD. Notably, the offering consists of 100% primary shares, indicating that the company intends to retain the capital raised rather than facilitating a cash-out for existing shareholders. The IPO is being managed by bookrunners J.P. Morgan, Barclays, and Jefferies, with J.P. Morgan acting as the stabilization agent. The company is led by CEO Caitlin Zulla and CFO Tony Martin.